 Connection
Olga Taraschenko to Status Epilepticus
This is a "connection" page, showing publications Olga Taraschenko has written about Status Epilepticus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.614 |
|
|
|
-
Gupta N, Baang HY, Barrett W, Reisbig K, Bendlin KA, Coleman SA, Samson K, Taraschenko O. Reducing seizure to needle times in nonconvulsive status epilepticus with multifaceted quality improvement initiatives. Epilepsy Res. 2023 02; 190:107085.
Score: 0.715
-
Malgireddy K, Gupta N, Baang HY, Samson KK, Madhavan D, Puccioni M, Taraschenko O. Risk of seizure clusters and status epilepticus following rapid and ultra-rapid medication discontinuation during intracranial EEG monitoring. Epilepsy Res. 2021 11; 177:106756.
Score: 0.652
-
Baang HY, Swingle N, Sajja K, Madhavan D, Shostrom VK, Taraschenko O. Towards Successes in the Management of Nonconvulsive Status Epilepticus: Tracing the Detection-to-Needle Trajectories. J Clin Neurophysiol. 2020 May; 37(3):253-258.
Score: 0.593
-
Meletti S, Hanin A, Giovannini G, Bedin R, Burani M, Taruffi L, Orlandi N, Urbano T, D'Achille F, Malerba M, Basha MM, Eschbach K, Foreman B, Farias-Moeller R, Gaspard N, Gerard EE, Gofton T, Gopaul MT, Haider HA, Hantus ST, Herman S, Kang P, Day GS, Kandula P, Steriade C, Struck AF, Taraschenko O, Wainwright M, Yoo JY, Zhou DJ, Lattanzi S, Navarro V, Hirsch LJ. Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus. JAMA Neurol. 2026 Jun 01; 83(6):563-572.
Score: 0.226
-
Hanin A, Marois C, Guillemaud M, Chavez M, Cosme L, Hayatou Z, Besnard A, Goudard G, Masson V, Cousyn L, Cheval M, Denis JA, Alkouri R, Lamari F, Bisulli F, Eschbach K, Farias-Moeller R, Gaspard N, Gerard EE, Giovannini G, Gofton T, Gopaul MT, Kellogg M, Meletti S, Muccioli L, Pasini E, Taraschenko O, Torcida N, Wainwright MS, Yoo JY, Wong N, Bonnefont-Rousselot D, Demeret S, Hirsch LJ, Navarro V. Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticus. Epilepsia. 2026 May; 67(5):2326-2346.
Score: 0.222
-
Gruen MD, Gopaul MT, Jimenez AD, Batra A, Blank LJ, Damien C, Day GS, Eschbach K, Gerard EE, Gofton TE, Hantus ST, Jette N, Jongeling A, Kang P, Kazazian K, Kellogg M, Kim M, Madani B, Morales M, Punia V, Steriade C, Struck A, Taraschenko O, Torcida N, Wainwright MS, Yoo JY, Gaspard N, Wong N, Hirsch LJ, Hanin A. Quality of life over time after new onset refractory status epilepticus. Epilepsia. 2026 01; 67(1):328-340.
Score: 0.215
-
Guillemaud M, Chavez M, Kobeissy F, Vezzani A, Jimenez AD, Basha MM, Batra A, Demeret S, Eka O, Eschbach K, Foreman B, Gaspard N, Gerard EE, Gofton TE, Haider HA, Hantus ST, Howe CL, Jongeling A, Kalkach-Aparicio M, Kandula P, Kazazian K, Kim M, Lai YC, Marois C, Mellor A, Mohamed W, Morales M, Pimentel CM, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Torcida Sedano N, Wainwright MS, Yoo JY, Wang KKW, Navarro V, Hirsch LJ, Hanin A. Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling. Neurol Neuroimmunol Neuroinflamm. 2025 Jul; 12(4):e200403.
Score: 0.210
-
Espino PH, Eschbach K, Blank LJ, Cervenka MC, Muscal E, Farias-Moeller R, Gilmore EJ, Gopaul MT, Haider HA, Hanin A, Hirsch LJ, Kellogg MA, Kluger G, Lee ST, Melendez-Zaidi AE, Navarro V, Oliger AC, Pasini E, Reuner G, Sharpe CM, Sheikh ZB, Steigleder L, Steriade C, Stredny CM, Strzelczyk A, Taraschenko O, van Baalen A, Vinette SA, Wickström R, Wong NW, Yoo J, Gofton TE. New onset refractory status epilepticus: Long-term outcomes beyond seizures. Epilepsia. 2025 Apr; 66(4):988-1005.
Score: 0.206
-
Hanin A, Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel CM, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Wainwright MS, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ. Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis. Epilepsia. 2024 Aug; 65(8):e148-e155.
Score: 0.197
-
Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel C, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ, Hanin A. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis. Epilepsia. 2024 Jun; 65(6):e87-e96.
Score: 0.195
-
Hanin A, Cespedes J, Pulluru Y, Gopaul M, Aronica E, Decampo D, Helbig I, Howe CL, Huttner A, Koh S, Navarro V, Taraschenko O, Vezzani A, Wilson MR, Xian J, Gaspard N, Hirsch LJ. Review and standard operating procedures for collection of biospecimens and analysis of biomarkers in new onset refractory status epilepticus. Epilepsia. 2023 06; 64(6):1444-1457.
Score: 0.182
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|